期刊文献+

miRNA-126基因敲减小鼠肠系膜淋巴结T淋巴细胞比例的变化 被引量:7

Change on proportion of T lymphocytes in mesenteric lymph nodes in miRNA-126 knockdown mice
下载PDF
导出
摘要 目的:研究miRNA-126基因敲减小鼠肠系膜淋巴结T及B淋巴细胞数量的变化。方法:检测miRNA-126基因敲减(KD)小鼠肠系膜淋巴结的体积、重量和淋巴结细胞总数;HE染色检测小鼠肠系膜淋巴结的病理形态学变化;流式细胞术(FACS)检测淋巴结中T及B淋巴细胞数量的变化。结果:与野生型(WT)小鼠相比,miR-126KD小鼠肠系膜淋巴结体积、重量和淋巴结细胞总数均显著增加(P<0.05),且病理形态学发生异常;肠系膜淋巴结中B淋巴细胞比例和数量无变化(P>0.05),CD4+T细胞数量无变化,而CD4+T细胞百分数明显减少(P<0.05),CD8+T细胞百分数和绝对数量均显著增加(P<0.05)。结论:miRNA-126敲减后可显著影响肠系膜淋巴结中T淋巴细胞的数量,提示miRNA-126可能影响肠系膜淋巴结的免疫功能。 Objective:To detect the change on proportion of T and B lymphocytes in mesenteric lymph nodes in miRNA-126 (miR-126) knockdown mice. Methods: The volume,weight and total cells number of mesenteric lymph node in miR-126 knockdown (KD) mice were measured;the pathologic morphology change of mesenteric lymph nodes was observed by HE staining;and the change on proportion of T and B lymphocytes in mesenteric lymph nodes in miR-126KD mice were analyzed by Flow cytometry. Results: Compared with those of WT mice, the volume and weight, as well as total cells number of mesenteric lymph node were significantly increased (P〈0. 05 ). Moreover, the pathologic morphology was significantly abnormal. The proportion and numbers of B lymphocyte, as well as absolute numbers of CD4~ T cells did not change significantly (P〉0. 05 ). However, the proportion of CD4+ T cells was remarkably decreased (P〈0. 05 ); moreover,the proportion and absolute numbers of CD8+ T cells were significantly increased(P〈 0. 05 ). Conclusion : There is significant influence in the numbers of T lymphocytes in mesenteric lymph nodes in miR-126KD mice, suggesting that miR-126 might play an important role in immunological function.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2014年第9期1157-1160,共4页 Chinese Journal of Immunology
基金 国家自然科学基金(81260398 31370918) 教育部"新世纪优秀人才计划"项目(NCET-12-0661)资助
关键词 miRNA-126基因敲减 肠系膜淋巴结 B细胞 T细胞 miRNA-126 knockdown Mesenteric lymph nodes B lymphocyte T lymphocyte
  • 相关文献

参考文献1

二级参考文献13

  • 1Mehmet Coskun,Jacob Tveiten Bjerrum,Jakob Benedict Seidelin,Jesper Thorvald Troelsen,JΦrgen Olsen,Ole Haagen Nielsen.miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis[J].World Journal of Gastroenterology,2013,19(27):4289-4299. 被引量:20
  • 2Daniel C Baumgart,William J Sandborn.Crohn’s disease[J]. The Lancet . 2012 (9853)
  • 3Ingrid Ordás,Lars Eckmann,Mark Talamini,Daniel C Baumgart,William J Sandborn.Ulcerative colitis[J]. The Lancet . 2012 (9853)
  • 4C. Liu,X. Xia,W. Wu,R. Wu,M. Tang,T. Chen,F. Xu,Y. Cong,X. Xu,Z. Liu.Anti‐tumour necrosis factor therapy enhances mucosal healing through down‐regulation of interleukin‐21 expression and T helper type 17 cell infiltration in C rohn’s disease[J].Clin Exp Immunol.2013(1)
  • 5Zahava Vadasz,Tharwat Haj,Aharon Kessel,Elias Toubi.B-regulatory cells in autoimmunity and immune mediated inflammation[J].FEBS Letters.2013(13)
  • 6Andrew L. Croxford,Florian Mair,Burkhard Becher.IL ‐23: One cytokine in control of autoimmunity[J].Eur J Immunol.2012(9)
  • 7Jean-Marie Berthelot,Christophe Jamin,Kahina Amrouche,Benoit Le Goff,Yves Maugars,Pierre Youinou.Regulatory B cells play a key role in immune system balance[J].Joint Bone Spine.2012
  • 8Thibault Griseri,Brent S. McKenzie,Chris Schiering,Fiona Powrie.Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation[J].Immunity.2012(6)
  • 9M.Gersemann,J.Wehkamp,E. F.Stange.Innate immune dysfunction in inflammatory bowel disease[J].Journal of Internal Medicine.2012(5)
  • 10Thomas T. MacDonald,Paolo Biancheri,Massimiliano Sarra,Giovanni Monteleone.What’s the next best cytokine target in IBD?[J].Inflamm Bowel Dis.2012(11)

共引文献16

同被引文献100

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部